Breakthrough diagnostic imaging and biomarker technologies are improving clinical management of complex diseases. The TriVerity biomarker test outperforms established infection markers for sepsis and ICU prognosis. Machine learning models automate precise tumor lymph node contouring in lung cancer radiotherapy planning. New neurodegeneration panels target key biomarkers for disorders such as Alzheimer’s and Parkinson’s. AI-enabled tools assist in intraoperative detection of brain tumors, enhancing surgical precision.